Open access
736
Views
0
CrossRef citations to date
0
Altmetric
Original Research
A randomized, double-blind, single-dose, phase 1 study comparing the pharmacokinetics, pharmacodynamics, safety, and immunogenicity of denosumab biosimilar CT‑P41 and reference denosumab in healthy males
Anhye Kima Department of Clinical Pharmacology and Therapeutics, CHA University School of Medicine, Seongnam, Republic of Korea
https://orcid.org/0000-0002-6622-8089View further author information
Jang Hee Hongb Department of Pharmacology, College of Medicine, Chungnam National University, Daejeon, Republic of Korea
https://orcid.org/0000-0002-0623-5455View further author information
Wonsuk Shina Department of Clinical Pharmacology and Therapeutics, CHA University School of Medicine, Seongnam, Republic of Korea
https://orcid.org/0000-0002-6163-5726View further author information
Hyounggyoon Yooa Department of Clinical Pharmacology and Therapeutics, CHA University School of Medicine, Seongnam, Republic of Korea
https://orcid.org/0000-0003-2785-4383View further author information
Jin-Gyu Jungb Department of Pharmacology, College of Medicine, Chungnam National University, Daejeon, Republic of Korea
https://orcid.org/0000-0002-2591-4867View further author information
Jean-Yves Reginsterc WHO Collaborating Center for Epidemiology of Musculoskeletal Health and Aging, Liège, Belgium;d College of Science, Kind Saud University, Riyadh, Kingdom of Saudi Arabia
https://orcid.org/0000-0001-6290-752XView further author information
SungHyun Kime Celltrion, Inc., Incheon, Republic of KoreaView further author information
, YunJu Baee Celltrion, Inc., Incheon, Republic of KoreaView further author information
, JeeHye Suhe Celltrion, Inc., Incheon, Republic of KoreaView further author information
, Sera Kime Celltrion, Inc., Incheon, Republic of KoreaView further author information
, EunKyung Leee Celltrion, Inc., Incheon, Republic of KoreaView further author information
& Stuart Silvermanf Department of Medicine, Division of Rheumatology, Cedars-Sinai Medical Center, Los Angeles, CA, USA;g OMC Clinical Research Center, Beverly Hills, CA, USACorrespondence[email protected]
https://orcid.org/0000-0002-5313-1018View further author information
Received 20 Dec 2023, Accepted 06 Feb 2024, Published online: 22 Feb 2024
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.